New solution for metastatic ovarian cancer based on approach from nearly a century ago shrinks tumors Aitrend
Nan Zhang (left) studies cancerous tumors in the laboratory – Courtesy of the Wistar Institute A new combination led to tumor regression in preclinical laboratory trials by scientists at the nonprofit Wistar Institute in Philadelphia. Ovarian cancer is the deadliest gynecological cancer, with low survival rates because it is naturally resistant to chemotherapy, so its … Read more